GLP-1 Market
GLP-1 Market Analysis, By Drug Type, By Route of Administration, By Indication, By Distribution Channel, By End-Use, By Age Group, and Region - Market Insights 2025 to 2035
Analysis of GLP-1 Market Covering 30+ Countries Including Analysis of U.S., Canada, U.K., Germany, France, Nordics, GCC countries, Japan, Korea and many more.
- FACT10786MR
- 19 May 2025
- Healthcare
- 170 Pages
- Tables
- Figures
Table of Content
- Executive Summary
- Industry Introduction, including Taxonomy and Market Definition
- Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
- Pricing Analysis
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
- Drug Type
- Route of Administration
- Indication
- Distribution Channel
- End-Use
- Age Group
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Drug Type
- Semaglutide
- Liraglutide
- Dulaglutide
- Exenatide
- Others
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Route of Administration
- Oral
- Injectable (Subcutaneous)
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Indication
- Type 2 Diabetes
- Obesity
- Cardiovascular Diseases
- Polycystic Ovary Syndrome (PCOS)
- Others
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Ovary
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End-Use
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Homecare Settings
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Age Group
- Pediatric (<12 years)
- Adolescents (12-17 years)
- Adults (18-64 years)
- Geriatric (65+ years)
- Women of Reproductive Age (15-49 years)
- Others
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- Middle East & Africa
- North America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Latin America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- East Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- South Asia & Pacific Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Western Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Eastern Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Middle East & Africa Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Sales Forecast to 2035 by Drug Type, Route of Administration, Indication, Distribution Channel, End-Use, and Age Group for 30 Countries
- Competitive Assessment, Company Share Analysis by Key Players, and Competition Dashboard
- Company Profile
- Novo Nordisk
- Eli Lilly
- AstraZeneca
- Sanofi
- Pfizer
- Glenmark Pharmaceuticals
- Biocon Ltd.
- Huadong Medicine
- Shanghai Benemae
- Hanmi Pharmaceutical
GLP-1 Market